FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, specifically to an agent showing hepatoprotective action. The agent showing hepatoprotective action of a herbal polyphenol extract of Amur maackia heartwood (Maxar) which represents an aqueous solution of Maxar in the molecular-capsulated form in the form of a water-soluble associated with a surfactant having a specific hydrophilic-lipophilic balance. A method for preparing the agent showing hepatoprotective action by Maxar homogenisation in the melt surfactant under certain conditions to produce the molecular-capsulated form of the end product.
EFFECT: agent shows higher biological accessibility and hepatoprotective activity ratio.
10 cl, 2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT SHOWING CARDIOPROTECTIVE ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2500396C2 |
| HEPATOPROTECTOR | 2011 |
|
RU2454243C1 |
| ANTIMENOPAUSAL DRUG | 2009 |
|
RU2398592C1 |
| HEPATOPROTECTIVE AND ANTI-INFLAMMATORY AGENT AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2009 |
|
RU2406496C1 |
| METHOD OF PRODUCING POLYPHENOL COMPLEX FROM AMUR MAACKIA HEARTWOOD | 2023 |
|
RU2822249C1 |
| AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
| ANTICANCER DRUG | 2009 |
|
RU2414920C1 |
| AGENT WITH ANTIPLATELET AND ANTICOAGULANT ACTIVITY | 2015 |
|
RU2601407C1 |
| PRODUCTION METHOD OF WATER-SOLUBLE FORMS OF BIOLOGICALLY ACTIVE SUBSTANCES | 2007 |
|
RU2388491C2 |
| AN ANTIVIRAL AGENT AGAINST SARS-COV-2 CORONAVIRUS | 2022 |
|
RU2788762C1 |
